跳至主要内容
临床试验/CTRI/2023/03/051058
CTRI/2023/03/051058尚未招募4 期

A Single Centric, Open-Label, Non-Randomized Phase IV Post- Marketing Surveillance Study to Measure the Efficacy and Safety of Product PETSAFFA Tablets in Subjects Suffering from Constipation, Gas and Acidity.

Divisa Herbals Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Age Between 18 and 80
  • 2.Subjects suffering from Constipation, Gas and Acidity
  • 3.Subjects willing to sign ICF
  • 4.Subjects willing to refrain taking any other similar medication during the study period.

排除标准

  • 1.Pregnant, breast-feeding subjects undergone any surgery and else take taken part in any clinical trial.
  • 2.Participation in any other clinical study (device or drug) within 30 days prior to Screening.
  • 3.Subjects with clinically significant serious cardiovascular, cerebrovascular, respiratory, hepatic, renal disease, congenital or any other disorder
  • 4.Subject with abnormal lab values detected at the time of screening shall be excluded.
  • 5.A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the investigational product.
  • 6.Pre-existing systemic disease necessitating long-term medications.
  • 7.Genetic and endocrinal disorder.
  • 8.Not willing to sign the ICF or give the consent.

研究者

发起方
Divisa Herbals Pvt. Ltd.

相似试验